{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:06:53Z","timestamp":1793210813455,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jhepr.2020.100113","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T11:25:07Z","timestamp":1585826707000},"page":"100113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":338,"title":["Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-055X","authenticated-orcid":false,"given":"Tobias","family":"Boettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario U.","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-0424","authenticated-orcid":false,"given":"Mojca","family":"Maticic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-7266","authenticated-orcid":false,"given":"Elisa","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-8001","authenticated-orcid":false,"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jhepr.2020.100113_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10229","key":"10.1016\/j.jhepr.2020.100113_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2020.100113_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhepr.2020.100113_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100113_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100113_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J\u00a0Pharm Anal"},{"issue":"10229","key":"10.1016\/j.jhepr.2020.100113_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100113_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100113_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100113_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100113_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jhep.2018.11.015","article-title":"Influenza virus infection as precipitating event of acute-on-chronic liver failure","volume":"70","author":"Sch\u00fctte","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100113_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2020.100113_bib13","article-title":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","author":"Chai","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jhepr.2020.100113_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.jhepr.2020.100113_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S2468-1253(20)30048-0","article-title":"Enteric involvement of coronaviruses: is faecal\u2013oral transmission of SARS-CoV-2 possible?","volume":"5","author":"Yeo","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100113_bib16","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2020.02.054","article-title":"COVID-19: gastrointestinal manifestations and potential fecal-oral transmission","volume":"158","author":"Gu","year":"2020","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.jhepr.2020.100113_bib17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJMp2003539","article-title":"Virtually perfect? Telemedicine for Covid-19","volume":"382","author":"Hollander","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100113_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2016.06.021","article-title":"Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices","volume":"65","author":"Maurice","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100113_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15869","article-title":"Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression","author":"Zhu","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhepr.2020.100113_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhin.2020.03.018","article-title":"Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy","author":"Colaneri","year":"2020","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhepr.2020.100113_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12879-020-4792-7","article-title":"Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010\/2011 to 2015\/2016","volume":"20","author":"Godoy","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2020.100113_bib22","unstructured":"Harrison C. Coronavirus puts drug repurposing on the fast track. 2020. Available from: https:\/\/www.nature.com\/articles\/d41587-020-00003-1. [Accessed 12 March 2020]."},{"key":"10.1016\/j.jhepr.2020.100113_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2020.100113_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"issue":"12","key":"10.1016\/j.jhepr.2020.100113_bib25","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhepr.2020.100113_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100113_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.jhepr.2020.100113_bib28","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100113_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jhepr.2020.100113_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhepr.2020.100113_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discoveries Ther"},{"key":"10.1016\/j.jhepr.2020.100113_bib32","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhepr.2020.100113_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","article-title":"Pain management in the cirrhotic patient: the clinical challenge","volume":"85","author":"Chandok","year":"2010","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jhepr.2020.100113_bib34","series-title":"COVID-19 Drug interactions","year":"2020"},{"key":"10.1016\/j.jhepr.2020.100113_bib35","first-page":"E019","article-title":"[Expert consensus on chloroquine phosphate for the treatment of novel\u00a0coronavirus pneumonia]","volume":"43","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Z"},{"key":"10.1016\/j.jhepr.2020.100113_bib36","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","author":"Al-Bari","year":"2017","journal-title":"Pharmacol Res Perspect"},{"issue":"15","key":"10.1016\/j.jhepr.2020.100113_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2020.100113_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1310\/hct1205-235","article-title":"Safety and pharmacokinetics of lopinavir in HIV\/HCV coinfected\u00a0patients with advanced liver disease","volume":"12","author":"Casado","year":"2011","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jhepr.2020.100113_bib39","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.40176","article-title":"Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis","volume":"69","author":"Genovese","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jhepr.2020.100113_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/1756-185X.13010","article-title":"Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation","volume":"20","author":"Chen","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jhepr.2020.100113_bib41","unstructured":"WHO. Clinical management of severe acute respiratory infection (SARI)\u00a0when COVID-19 disease is suspected. 2020. Available from: https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. [Accessed 18 March 2020]."},{"issue":"16","key":"10.1016\/j.jhepr.2020.100113_bib42","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2020.100113_bib43","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.02282-12","article-title":"Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans","volume":"57","author":"Deng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhepr.2020.100113_bib44","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jhepr.2020.100113_bib45","unstructured":"HEP Drug interactions. 2020. Available from: https:\/\/www.hep-druginteractions.org\/. [Accessed 20 March 2020]."},{"key":"10.1016\/j.jhepr.2020.100113_bib46","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2020.100113_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100113_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2020.100113_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s13063-019-3606-y","article-title":"A\u00a0phase 1\/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)","volume":"20","author":"Ramsey","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jhepr.2020.100113_bib50","unstructured":"Press release on planned clinical trials to evaluate anakinra and emapalumab in COVID-19. 2020. Available from: https:\/\/www.sobi.com\/en\/press-releases\/sobi-initiate-clinical-study-evaluate-whether-anakinra-and-emapalumab-may-relieve. [Accessed 30 March 2020]."}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:24:50Z","timestamp":1762899890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920300471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2589555920300471"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100113","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100113"}}